Vanguard Capital Wealth Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,485
| Closed | -$393K | – | 153 |
|
|
2024
Q2 | $393K | Buy |
2,485
+35
| +1% | +$5.53K | 0.27% | 81 |
|
|
2024
Q1 | $317K | Hold |
2,450
| – | – | 0.22% | 90 |
|
|
2023
Q4 | $236K | Buy |
2,450
+90
| +4% | +$8.68K | 0.19% | 110 |
|
|
2023
Q3 | $286K | Buy |
2,360
+10
| +0.4% | +$1.21K | 0.27% | 79 |
|
|
2023
Q2 | $269K | Hold |
2,350
| – | – | 0.24% | 89 |
|
|
2023
Q1 | $324K | Hold |
2,350
| – | – | 0.32% | 70 |
|
|
2022
Q4 | $305K | Hold |
2,350
| – | – | 0.35% | 70 |
|
|
2022
Q3 | $260K | Buy |
+2,350
| New | +$260K | 0.32% | 77 |
|
|
2022
Q1 | – | Sell |
-2,400
| Closed | -$216K | – | 167 |
|
|
2021
Q4 | $216K | Hold |
2,400
| – | – | 0.16% | 125 |
|
|
2021
Q3 | $222 | Buy |
+2,400
| New | +$222 | 0.15% | 128 |
|
|
2021
Q1 | – | Sell |
-4,250
| Closed | -$729K | – | 161 |
|
|
2020
Q4 | $729K | Buy |
+4,250
| New | +$729K | 0.67% | 38 |
|
|
2020
Q2 | $729K | Buy |
+4,550
| New | +$729K | 0.85% | 33 |
|
|
2019
Q4 | $625K | Buy |
4,850
+650
| +15% | +$83.8K | 0.65% | 41 |
|
|
2019
Q3 | $316K | Sell |
4,200
-500
| -11% | -$37.6K | 0.37% | 81 |
|
|
2019
Q2 | $714K | Hold |
4,700
| – | – | 0.86% | 35 |
|
|
2019
Q1 | $560K | Hold |
4,700
| – | – | 0.7% | 44 |
|
|
2018
Q4 | $512K | Sell |
4,700
-200
| -4% | -$21.8K | 0.76% | 43 |
|
|
2018
Q3 | $791K | Hold |
4,900
| – | – | 0.9% | 28 |
|
|
2018
Q2 | $647K | Sell |
4,900
-100
| -2% | -$13.2K | 0.86% | 43 |
|
|
2018
Q1 | $359K | Sell |
5,000
-300
| -6% | -$21.5K | 0.47% | 64 |
|
|
2017
Q4 | $295K | Buy |
+5,300
| New | +$295K | 0.37% | 80 |
|